Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01400776 · ClinicalTrials.gov registry record · Phase 3
Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women
A Phase 3 study of Postmenopausal Vulvovaginal Atrophy, sponsored by Warner Chilcott.
- Completed
- Registry status
- Phase 3
- Development phase
- 722
- Enrollment target
- 20
- Study locations
NCT01400776 is a Phase 3 study of Postmenopausal Vulvovaginal Atrophy that has completed, run by Warner Chilcott. The registered enrollment target is 722 participants. The trial reports 20 study locations across 6 states.
The verdict
NCT01400776, a Phase 3 study of Postmenopausal Vulvovaginal Atrophy, has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 722 participants
- Enrollment target
- 20
- Study locations
Study Summary
Study if WC3011 is effective and safe in the treatment of postmenopausal vaginal dryness due to vulvovaginal atrophy.
Conditions Studied
Interventions
- DRUG Vehicle
- DRUG WC3011 Estradiol Vaginal Cream
Study Locations (20)
Florida
- Visions Clinical Research - Boynton Beach
- Women's Medical Research Group, LLC - Clearwater
- Jacksonville Center for Clinical Research - Jacksonville
- Miami Research Associates - Miami
- New Age Medical Research Corp - Miami
- Ormond Medical Arts Pharmaceutical Research Center - Ormond Beach
- OB-GYN Specialists of the Palm - Palm Beach Gardens
- Radiant Research-St. Petersburg - Pinellas Park
Arizona
- Women's Health Research - Phoenix
- Precision Trials, LLC - Phoenix
- Radiant Research-Scottsdale - Scottsdale
- Radiant Research-Tucson - Tucson
- Visions Clinical Research-tucson - Tucson
California
- Genesis Center for Clinical Research - San Diego
- Medical Center for Clinical Research - San Diego
- Women's Healthcare Inc. - San Diego
Alabama
- Medical Affiliated Research Center, Inc. - Huntsville
- Mobile OB-GYN, PC - Mobile
Colorado
- Physicians' Research Options LLC - Lakewood
Connecticut
- Costal Connecticut Resarch, LLC - New London
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 722 participants |
| Start Date | 2011-06-29 |
| Est. Completion | 2012-02-27 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01400776
The ClinicalTrials.gov registry entry for NCT01400776 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 722 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Warner Chilcott, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postmenopausal Vulvovaginal Atrophy appearing as the primary indexed condition, and to 2 interventions - of which Vehicle is the first listed.
NCT01400776 reports 20 study locations spanning 6 distinct geographic areas - top geographies include Florida, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT01400776 about?
NCT01400776 is a clinical study titled "Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women". Study if WC3011 is effective and safe in the treatment of postmenopausal vaginal dryness due to vulvovaginal atrophy.
What is the current status of trial NCT01400776?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 722 participants. The study started on 2011-06-29. Estimated completion is 2012-02-27.
What conditions does trial NCT01400776 study?
This clinical trial studies the following conditions: Postmenopausal Vulvovaginal Atrophy.
What interventions are being tested in trial NCT01400776?
The interventions under investigation include: Vehicle (DRUG), WC3011 Estradiol Vaginal Cream (DRUG).
Who is sponsoring clinical trial NCT01400776?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01400776 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.